Press releases
- Press releases
- Browse
Press releases
Everygene applies for PTC patent for its discoveries More
Everygene AB provides new consulting services More
Appointment reflects Borean Pharma's progress towards the execution of its business strategy of partnering and licensing More
Borean Pharma A/S, the Aarhus-based biopharmaceutical and protein engineering company, today announced that it has reached a key technological milestone by producing protein products with high affinity binding in the 100 - 200 picomolar range. More
SYN•X receives CE Mark allowing for sales of the Nexus Dx(tm) point-of-care cardiac product line in Europe More
Mintz & Associates published in Pharmalicensing's Partnering Focus Supplement to Bio2003 More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jul 2011 - 140 pages - $2,500
Apr 2011 - 103 pages - $2,500
Apr 2011 - 103 pages - $2,500
Apr 2011 - 104 pages - $2,500
Mar 2011 - 102 pages - $2,500
Apr 2011 - 105 pages - $2,500
Mar 2011 - 100 pages - $2,500
Mar 2011 - 104 pages - $2,500
Mar 2011 - 106 pages - $2,500
Mar 2011 - 104 pages - $2,500
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us